共 37 条
[11]
Luo N., Chew L.H., Fong K.Y., Koh D.R., Ng S.C., Yoon K.H., Vasoo S., Li S.C., Thumboo J., Validity and reliability of the EQ-5D self-reported questionnaire in English-speaking patients with rheumatic diseases in Singapore, Ann. Acad. Med. Singapore
[12]
Dolan P., Modelling valuations for EuroQol health states, Med. Care, 35, pp. 1095-1108, (1997)
[13]
Dolan P., Roberts J., Modelling valuations for Eq-5d health states: An alternative model using differences in valuations, Med. Care, 40, pp. 442-446, (2002)
[14]
Gold M.R., Patrick D.L., Torrance G.W., Fryback D.G., Hadorn D.C., Kamlet M.S., Daniels N., Weinstein M.C., Identifying and valuing outcomes, Cost-Effectiveness in Health and Medicine, pp. 82-134, (1996)
[15]
Drummond M.F., O'Brien B.J., Stoddart G.L., Torrance G.W., Cost-utility analysis, Methods for the Economic Evaluation of Health Care Programmes, pp. 139-199, (1997)
[16]
Kind P., Hardman G., Macran S., UK population norms for EQ-5D, (1999)
[17]
Jones B., Jarvis P., Lewis J.A., Ebbutt A.F., Trials to assess equivalence: The importance of rigorous methods, BMJ, 313, pp. 36-39, (1996)
[18]
Chadwick D., Monotherapy comparative trials: Equivalence and differences in clinical trials, Epilepsy Res., 45, pp. 101-103, (2001)
[19]
Jaeschke R., Singer J., Guyatt G.H., Measurement of health status. Ascertaining the minimal clinically important difference, Control Clin. Trials, 10, pp. 407-415, (1989)
[20]
Brazier J., Jones N., Kind P., Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire, Qual. Life Res., 2, pp. 169-180, (1993)